Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.

Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.

Nipah virus (NiV) disease is a bat-borne zoonosis responsible for outbreaks with high lethality and is a priority for vaccine development. With funding from the Coalition of Epidemic Preparedness Innovations (CEPI), we are developing a chimeric vaccine (PHV02) composed of recombinant vesicular stoma...

Full description

Bibliographic Details
Main Authors: Thomas P Monath, Richard Nichols, Lynda Tussey, Kelly Scappaticci, Thaddeus G Pullano, Mary D Whiteman, Nikos Vasilakis, Shannan L Rossi, Rafael Kroon Campos, Sasha R Azar, Heidi M Spratt, Brent L Seaton, W Tad Archambault, Yanina V Costecalde, Evan H Moore, Roger J Hawks, Joan Fusco
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-06-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1010658

Internet

https://doi.org/10.1371/journal.ppat.1010658

Similar Items